Dr. Alejandro Hoberman

powered by
COS Expertise®
University of Pittsburgh
School of Medicine
Pediatrics
ProfessorAppointed: 1992
University of Pittsburgh
School of Medicine
Children's Hospital of Pittsburgh
General Academic Pediatrics
Division ChiefAppointed: 2001
Children's Hospital of Pittsburgh
Pediatric Research
Jack L. Paradise ProfessorAppointed: 2000
University of Pittsburgh
School of Medicine
Magee-Womens Hospital
Newborn
ProfessorAppointed: 1992
Professional Headshot of Alejandro Hoberman

Mailing Address

Children's Hospital of Pittsburgh
General Academic Pediatrics
3705 Fifth Avenue
CHOB
Pittsburgh, Pennsylvania 15213-2583
United States

Contact Information

Phone: (412) 692-5249
Fax: (412) 692-5807
hoberman@chp.edu
http://www.chp.edu

Qualifications

Certified, Harvard University, Leadership Development for Physicians in Academic Health Centers, 2004.
Recertified Diplomate, American Board of Pediatrics, 2003.
Certified, Katz School of Business, Business and Leadership, 2002.
Diplomate, American Board of Pediatrics, 1997.
Fellowship, Children's Hospital of Pittsburgh, Ambulatory Pediatrics and Community Medicine, 1992.
Diplomate, Argentine Pediatric Society, 1987.
M.D., National University of Buenos Aires, 1983.
General, Children's Hospital of Buenos Aires, Pediatrics Residency, 1983.
B.S., National College of Buenos Aires, 1977.

Expertise and Research Interests

My research interests have included the prevention, diagnosis and treatment of two of the most frequently occurring pediatric conditions, acute otitis media (AOM) and urinary tract infections (UTI). AOM is the most common pediatric illness for which antibiotics are prescribed; 3 of 4 children have AOM by age 3. UTI is the most frequently occurring serious bacterial illness, particularly in young febrile children.

In the area of UTIs my research has evaluated (1) the prevalence of UTIs in young febrile infants, (2) diagnostic screening tests to identify children with UTI, (3) follow-up imaging studies performed in children following an initial episode of UTI, and (4) treatment options, particularly a comparison of outpatient vs. inpatient therapy in young febrile children. Together with Diana Kearney, RN, CRC, I developed a videotape aimed at instructing clinicians in the performance of bladder catheterization and in the evaluation of a uncentrifuged urine specimen using a hemocytometer.

In the area of AOM, my research has included the evaluation of (1) antimicrobials treatment regimens, (2) topical otic analgesic medication, (3) the seasonality of antimicrobial resistance, and (4) the efficacy of influenza vaccine in preventing AOM in young children.

In the area of medical education, with Dr. Phillip H. Kaleida, we developed a multimedia educational series of otoendoscopic examinations for self-training on the use of pneumatic otoscopy. A second multimedia program had the objective of instructing the distinction between AOM from otitis media with effusion. These multimedia educational programs aimed at improving diagnostic accuracy in children with AOM, and have been used in instructing large number of trainees and audiences worldwide. Again, with Dr. Kaleida and other members of the Division of General Academic Pediatrics, we developed a program to help train medical residents across the country in the diagnosis of AOM. We secured funding from the Centers for Disease Control and Prevention (CDC) and the Association of American Medical Colleges (AAMC) for the development of an innovative project called ePROM (enhancing PRoficiency in Otitis Media). This program includes web-based interactive modules; individualized telemedicine feedback, and reinforcement of skill by training champions at each residency program.

Over the years, I have also been the principal investigator of a collaborative -- General Pediatrics and General Internal Medicine -- Faculty Development in Primary Care Training Program, funded by the Health Resources Services Administration (HRSA). The overall purpose of this collaborative faculty development program has been to create a new generation of Primary Care Clinician Researchers in pediatrics, internal medicine and medicine-pediatrics. These individuals must work effectively in interdisciplinary teams, address public health priorities, be culturally competent, consult those who are impacted by their care and research, and develop leadership skills to translate results into policy.

In 2005, I received funding from NIDDK as the Principal Investigator of a Pediatric Nephrology/Urology Clinical Treatment Center that will conduct at Children's Hospital of Pittsburgh -- in collaboration with 5 additional sites in the US -- a large randomized, placebo-controlled study evaluating the efficacy of antimicrobial prophylaxis in young children with vesicoureteral reflux diagnosed following an initial UTI. In 2006, I was also awarded a grant from NIAID/NICHD to study in a randomized, placebo-controlled trial, the efficacy of antimicrobial treatment in young children with AOM. Patient enrollment in these studies is anticipated to commence in last quarter of 2006.

I graduated from medical school in Buenos Aires, Argentina, where I completed a General Pediatrics Residency at the Children's Hospital of Buenos Aires. I then came to the US for Fellowship training in Ambulatory Pediatrics at the Children's Hospital of Pittsburgh, under Jack L. Paradise and Kenneth Rogers. Immediately following fellowship I joined the faculty at the University and Children's Hospital of Pittsburgh where I currently lead the Division of General Academic Pediatrics. My research findings have been published in the New England Journal of Medicine, JAMA and other highly rated peer-reviewed journals. In 2000, I was honored by being endowed as the first Jack L. Paradise, M.D., Professor of Pediatric Research.

Keywords

COS Keywords:

Ambulatory Care, Breast Milk, Child Or Maternal Health, Deafness, Image Processing, Infectious Diseases Or Agents, Kidney Disease, Medical Diagnosis, Neonatology, Pediatrics, Urology.

Additional Terms:

Otitis Media, Urinary Tract Infections.

Languages

(Reading, Writing, Speaking)

English: (Fluent, Fluent, Fluent)
French: (Functional, Functional, Functional)
Spanish: (Fluent, Fluent, Fluent)

Memberships

Ambulatory Pediatric Association
American Academy of Pediatrics
Argentine Pediatric Society
International Society of Pediatric Otolaryngology
National Institute on Deafness and Other Communication Disorders
Society for Pediatric Research

Honors and Awards

2005, Pediatric Grand Rounds First Annual Richard H. Rapkin Memorial Lecturer, University of Medicine and Dentistry of New Jersey, New Jersey School of Medicine, Urinary Tract Infections in Young Children: Controversies in Management and Imaging Studies
2001, Contemporary Pediatrics, Journal Club: The top 10 of 1999; Outpatient Therapy for Infants with UTIs
2000, Jack L. Paradise Professor of Pediatric Research Children's Hospital of Pittsburgh
2000, Pediatric News, The Year's Best Articles on Infectious Diseases; Oral vs. Intravenous Therapy for UTI in Young Febrile Children
1999, Member, Society for Pediatric Research
1983, Honors Diploma, National University of Buenos Aires School of Medicine

Previous Positions

1989-1992, Fellow, University of Pittsburgh, School of Medicine, Pediatrics, Ambulatory Pediatrics
1988-1989, Partner, Pediatric Prevention Center, Buenos Aires
1984-1988, Intern, Resident, Children's Hospital of Buenos Aires, General Pediatrics

Funding Received

  • NIAID-NICHD: Efficacy of Antimicrobials in Young Children with AOM, $1,835,281, 2006 to 2008.
  • Health Resources and Services Administration: Faculty Development in Primary Care, $1,261,627, 2005 to 2008.
  • NIDDK: Efficacy of Prophylactic Antimicrobials in Children with VUR, $2,079,094, 2005 to 2010.
  • Sanofi-Aventis: Telithromycin vs Cefuroxime Axetil in Children with AOM, $31,425, 2005 to 2007.
  • Association of American Medical Colleges/CDC Foundation: ePROM, Enhancing Proficiency of Residents in Diagnosing Otitis Media, $550,000, 2004 to 2006.
  • SmithKline: Efficacy of 7-Valent Pneumococcal Conjugate Vaccine (PCV7, Prevnar) in Preventing Nasopharyngeal Colonization with Non-susceptible S. Pneumoniae, $855,542, 2004 to 2005.
  • SmithKline: Development of Educational Materials for More Accurate Diagnosis & Managment of AOM, $100,000, 2003 to 2003.
  • Pfizer: A Randomized, Multicenter, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Vs Amoxicillin/Clavulanate Potassium s (augmentin ES-600) for the Treatment of AOM in Children Undergoing Diagnostic Tympanocentesis, $247,575, 2003 to 2005.
  • Pennsylvania Department of Health: Community-Based Healthcare Assistance Grants for Resources, $186,230, 2002 to 2003.
  • Health Resources and Services Administration: Faculty Development in Primary Care, $1,403,139, 2002 to 2005.
  • Association of Teachers of Preventive Medicine/CDC Foundation: Influenza Vaccination of Children in the Inner City, $74,700, 2002 to 2005.
  • Abbott: An Open-Label Safety and Efficacy Study of Cefdinir Suspension, 25 mg/kg Once Daily in Pediatric Subjects with Acute Otitis Media, $135,550, 2002 to 2003.
  • Pfizer: A Randomized, Multicenter, Double-Blind, Double-Dummy Trial of Single-Dose Zithromax (azithromycin) Versus High-Dose Amoxicillin in the Treatment of Children Ages 6 Months to 30 Months, $143,255, 2002 to 2003.
  • SmithKline Beecham: A Randomized, Investigator-blind, Multicenter Study to Assess the Efficacy of Oral Augmentin ES 600 Twice Daily for 10 Days Versus Oral Zithromax Once Daily for 5 Days in the Treatment of Acute Otitis Media in Infants and Children, $308,000, 2001 to 2002.
  • Pfizer: A Randomized, Multicenter, Double-Blind, Double-Dummy Trial of High-Dose Azithromycin Versus High-Dose Amoxicillin/Clavulanate in the Treatment of Children with Recurrent or Persistent Acute Otitis Media, $163,800, 2001 to 2002.
  • Pfizer Laboratories: A Multicenter, Open Label, Non-Comparative Trial of a Single Dose of 30 mg/kg Azithromycin in the Treatment of Acute Otitis Media in Pediatric Subjects Undergoing Tympanocentesis, $11,070, 2000 to 2000.
  • Tap Holdings, Inc.: Comparative Safety and Efficacy of Cefditoren Pivoxil in the Treatment of Children with Refractory Acute Otitis Media, $5,000, 2000 to 2000.
  • SmithKline Beecham Pharmaceuticals: An Open Label Study to Demonstrate Bacteriologic Efficacy of Augmentin ES in the Treatment of Acute Otitis Media due to S. Pneumoniae, $277,740, 1999 to 2000.
  • Aventis Pasteur: Efficacy of Influenza Vaccine (Fluzone) in the Prevention of Acute Otitis Media, $3,898,719, 1999 to 2001.
  • Tap Holdings Inc.: Comparative Safety and Efficacy of Cefditoren Pivoxil and Cefprozil (Cefzil) Suspensions in the Treatment of Children with Acute Otitis Media, $160,000, 1999 to 2000.
  • Tap Holdings Inc.: Comparative Safety and Efficacy of Cefditoren Pivoxil and Amoxicillin Clavulanate Potassium (Augmentin) Suspensions in the Treatment of Children with Acute Otitis Media, $40,967, 1999 to 2000.
  • Maternal and Child Health Bureau: Clinical Predictors in Identifying Young Children with Urinary Tract Infections, $15,000, 1999 to 2000.
  • Health Resources and Services Administration: Faculty Development in Primary Care, $844,966, 1999 to 2003.
  • Lilly Research Laboratories: Cefaclor Versus Cefuroxime in Children with 'Difficult-To-Treat' Acute Otitis Media, $250,000, 1998 to 1999.
  • SmithKline Beecham Pharmaceuticals: A Comparison of the Safety and Efficacy of Augmentin vs. Zithromax for 5 Days in the Treatment of Acute Otitis Media in Children, $142,200, 1997 to 1997.
  • Lilly Research Laboratories: Safety and Efficacy of Higher Doses of Lorabid in Children with 'Difficult-To-Treat' Acute Otitis Media, $275,000, 1997 to 1998.
  • SmithKline Beecham Pharmaceuticals: Efficacy of Bactroban Nasal in Eradicating Nasopharyngeal Colonization in Young Children, $359,270, 1996 to 1997.
  • SmithKline Beecham Pharmaceuticals: A Comparison of the Safety and Efficacy of Augmentin 90/6.4 mg/kg/d and Augmentin 45/6.4 mg/kg/d in the Treatment of Acute Otitis Media in Children, $195,420, 1996 to 1997.
  • Research Advisory Committee, Children's Hospital of Pittsburgh: Acute Otitis Media in Patients with Bronchiolitis, $10,000, 1996 to 1997.
  • Research Advisory Committee, Children's Hospital of Pittsburgh: Efficacy of Metoclopramide as Treatment of Lactation Insufficiency, $10,000, 1995 to 1996.
  • SmithKline Beecham Pharmaceuticals: Equivalent Efficacy and Reduced Occurrence of Diarrhea from a New Formulation of Amoxicillin/Clavulanate Potassium (Augmentin) for Treatment of Acute Otitis Media in Children, $91,500, 1994 to 1994.
  • SmithKline Beecham Pharmaceuticals: Efficacy and Safety of Augmentin in the Treatment of Acute Otitis Media due to Penicillin Resistant Pneumococcus in Children, $232,975, 1994 to 1994.
  • NICHD: Child Development in Relation to Early Otitis Media, $4,187, 1994 to 1995.
  • Mc Neil Consumer Products Company: Efficacy of Auralgan for Ear Pain in Children with Acute Otitis Media, $7,500, 1992 to 1994.
  • Lederle - Wyeth Ayerst Laboratories: Oral vs intravenous therapy for acute pyelonephritis in children 1-24 months, $528,000, 1991 to 1997.
  • Research Advisory Committee, Children's Hospital of Pittsburgh: Oral vs. Intravenous Therapy for Acute Pyelonephritis in Children 1-24 mos, $65,380, 1991 to 1997.
  • General Clinical Research Center, Children's Hospital of Pittsburgh: Oral vs. intravenous therapy for acute pyelonephritis in children 1-24 months, $117,144, 1991 to 1997.
  • Abbott Laboratories: Safety and Efficacy of Clarithromycin vs. Augmentin for Children with Acute Otitis Media, $84,000, 1991 to 1992.
  • General Clinical Research Center, Children's Hospital of Pittsburgh: Design and Evaluation of an Educational Intervention to Enhance Otoscopic Diagnostic Accuracy of First-year Pediatric Residents, $6,450, 1990 to 1991.
  • Research Advisory Committee, Children's Hospital of Pittsburgh: Prevalence of Urinary Tract Infection in Febrile Infants, $14,220, 1990 to 1991.
  • General Clinical Research Center, Children's Hospital of Pittsburgh: Prevalence of Urinary Tract Infection in Febrile Infants, $22,066, 1990 to 1991.

Publications

  • RK Zimmerman, A Hoberman, MP Nowalk, CJ Lin, DP Greenberg, ST Weinberg, FS Ko, DE Fox (2006) Improving Influenza Vaccination of High Risk Inner-City Children Over Two Intervention Years, Annals of Family Medicine, In Press
  • A Arguedas, R. Dagan, E Leibovitz, A Hoberman, M Pichichero, M Paris (2006.) A Multicenter, Open-Label, Double Tympanocentesis Study of High-Dose Cefdinir in Children with Acute Otitis Media at High Risk of Persistent or Recurrent Infection, Pediatric Infectious Disease Journal, 25, 211-218.
  • CJ Lin, RK Zimmerman, MP Nowalk, FS Ko, M Raymund, A Hoberman, DH Kearney, B Block (2006.) Parental Perspectives on Influenza Vaccination of Children with Chronic Medical Conditions, Journal of the National Medical Association, 98 (2), 148-153.
  • JL Chyongchiou, MP Nowalk, RK Zimmerman, FS Ko, L Zoffel, A Hoberman, D Kearney (2006) Beliefs and Attitudes about Influenza Immunization among Parents of Children with Chronic Medical Conditions over a Two-Year Period, Journal of Urban Health: Bulletin of the New York Academy of Medicine, 83 (5), 874-883
  • A Hoberman, D Greenberg, JL Paradise, E Wald, DH Kearney, DK Colborn, Penicillin Susceptibility of Pneumococcal Isolates Causing Acute Otities Media in Children, Pediatric Infectious Disease Journal, 24(2), 115-120, 2005
  • A Hoberman, Commentary Regarding the Article "A Randomized, Placebo-Controlled Trial of the Effect of Antihistamine of Corticosteroid Treatment in Acute Otitis Media.", 2005 Year Book of Pediatrics, St. Louis, MO, Mosby-Year Book, 2005
  • A Hoberman, R Dagan, E Leibovitz, A Rosenblut, CE Johnson, A Huff, R Bandekar, B Wynne (2005.) Large Dosage Amoxicillin/Clavulanate, Compared with Azithromycin for the Treatment of Bacterial Acute Otitis Media in Children, Pediatric Infectious Diseases Journal, 24, 525-532.
  • MP Nowalk, CJ Lin, RK Zimmerman, JA Troy, A Hoberman, DH Kearney, SM Cleary (2005.) Tailored Interventions to Introduce Influenza Vaccination among 6-23 Month Old Children at Inner-City Health Centers, American Journal of Managed Care, 11, 717-724.
  • MP Nowalk, RK Zimmerman, CJ Lin, FS Ko, M Raymund, A Hoberman, DH Kearney, DP Greenberg (2005) Parental Perspectives on Influenza Immunization of 6-23 Month Old Children, American Journal of Preventive Medicine, 29, 210-214
  • Hoberman A, Paradise JL, Study Design Questions in Treatment of Children With Acute Otitis Media., Antimicrobial Agents and Chemotherapy, 48(7), 2784; author reply 2, 2004
  • Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR Jr, Yawn B, American Academy of Pediatrics Subcommit, American Academy of Family Physicians, American Academy of Otolaryngology--Head, Clinical Practice Guideline: Otitis Media With Effusion., Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-head and Neck Surgery., 130(5 Suppl), S95-118, 2004
  • Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR Jr, Yawn B, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion, American Academy of Family Physicians, American Academy of Otolaryngology--Head and Neck Surgery (May 2004) Clinical practice guideline: Otitis media with effusion., Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-head and Neck Surgery., 130 (5 Suppl), S95-118 Abstract
  • RK Zimmerman, A Hoberman, MP Nowalk, CJ Lin, DP Greenberg, ST Weinberg, CW Bemm, B Block (2004.) Feasibility of Influenza Immunization for Inner-City Children Aged 6 to 23 Months, American Journal of Preventive Medicine, 27 (5), 397-403.
  • A Hoberman, D Greenberg, JL Paradise (2004) Reply to a Letter to the Editor regarding the Article "Effectiveness of Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Young Children, JAMA, 291 (6), 69.
  • A Hoberman, JL Paradise (2004) Letter to the Editor regarding the Article "High-Dose Amoxicillin-Clavulanate for Treatment of Children with Recurrent or Persistent Acute Otitis Media, Antimicrobial Agents in Chemotherapy, 48, 7.
  • Shaikh N, Hoberman A, Wise B, Kurs-Lasky M, Kearney D, Naylor S, Haralam MA, Colborn DK, Docimo SG, Dysfunctional Elimination Syndrome: Is It Related to Urinary Tract Infection or Vesicoureteral Reflux Diagnosed Early In Life?, Pediatrics, 112(5), 1134-7, 2003
  • Hoberman A, Greenberg DP, Paradise JL, Rockette HE, Lave JR, Kearney DH, Colborn DK, Kurs-Lasky M, Haralam MA, Byers CJ, Zoffel LM, Fabian IA, Bernard BS, Kerr JD, Effectiveness of Inactivated Influenza Vaccine in Preventing Acute Otitis Media in Young Children: a Randomized Controlled Trial., Journal of the American Medical Association, 290(12), 1608-16, 2003
  • Hoberman A, Charron M, Hickey RW, Baskin M, Kearney DH, Wald ER, Imaging Studies after a First Febrile Urinary Tract Infection in Young Children, New England Journal of Medicine, 348(3), 195-202, 2003
  • MD Pichichero, A Hoberman, RN Jones, MD Reed (2003) Editorial on Antimicrobial Options in Acute Otitis Media: Focus on Cephalosporins, Dialogues in Acute Otitis Media.
  • A Hoberman, RW Hickey, ER Wald (2003) Reply to Letters to the Editor regarding the Article "Imaging Studies after a First Febrile Urinary Tract Infection in Young Children, New England Journal of Medicine, 348, 1812-1814.
  • MH Gorelick, A Hoberman, DH Kearney, ER Wald, KN Shaw, Validation of a decision rule identifying febrile young girls at high risk for urinary tract infection, Pediatric Emergency Care, 2002
  • MD Poole, MR Jacobs, JB Anon, CD Marchant, A Hoberman, CJ Harrison, Antimicrobial guidelines for the treatment of acute bacterial rhinosinusitis in immunocompetent children, Int J Pediatr Otolaryngol, 63, 1-13, 2002
  • A Hoberman, CD Marchant, SL Kaplan, S Feldman, Treatment of acute otitis media: Consensus recommendations, Clinical Pediatrics, (in press), 2002
  • R Dagan, A Hoberman, C Johnson, EL Leibovitz, A Arguedas, FV Rose, BR Wynne, MR Jacobs, Bacteriologic and clinical efficacy of high-dose amoxicillin/clavulanate in children with acute otitis media, including penicillin-resistant Streptococcus pneumoniae, Pediatric Infectious Disease Journal, 20, 829-37, 2001
  • ER Wald, D Greenberg, A Hoberman, Short-term oral cefixime therapy for treatment of bacterial conjunctivitis, Pediatric Infectious Disease Journal, 20, 1041-4, 2001
  • D Greenberg, A Hoberman, Vaccine prevention of acute otitis media, Current Allergy and Asthma Reports, 1, 358-63, 2001
  • A Hoberman, ER Wald, RW Hickey, et al. (2001) Oral Versus Initial Intravenous Therapy for Urinary Tract Infections in Young Febrile Children, Year Book of Pediatrics, Stockman JA III, Editor (Mosby-Year Book Inc., St. Louis, MO), 160-162.
  • Hoberman A, Paradise JL, Cohen R, Duration of Therapy for Acute Otitis Media, Pediatric Infectious Disease Journal, 19, 471-3, 2000
  • Hoberman A, Paradise JL, Acute Otitis Media: Diagnosis and Management, Pediatric Annals, 29, 609-20, 2000
  • A Hoberman, ER Wald (2000) Reply to a Letter to the Editor regarding the Article "Oral Versus Intitial Intravenous Therapy for Urinary Tract Infections in Young Febrile Children, Pediatrics, 106, 865.
  • A Hoberman, ER Wald, RW Hickey et al. (2000) Oral Versus Intitial Intravenous Therapy for Urinary Tract Infections in Young Febrile Children, Year Book of Urology, Andriole GL Jr, Coplen DE, Editors (Mosby-Year Book Inc., St. Louis MO), 291-293.
  • A Hoberman, ER Wald, RW Hickey et al. (2000) Oral Versus Initial Intravenous Therapy for Urinary Tract Infections in Young Febrile Children, Year Book of Emergency Medicine, Burdick WP, Editor (Mosby-Year Book Inc., St. Louis, MO), 160-162.
  • Hoberman A, Wald ER, Treatment of urinary tract infections, Pediatric Infectious Disease Journal, 18(11), 1020-1, 1999 Abstract
  • Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Kearney DH, Reynolds EA, Ruley J, Janosky JE, Oral versus initial intravenous therapy for urinary tract infections in young febrile children, Pediatrics, 104, 79-86, 1999
  • Hoberman A, Wald ER, Treatment of urinary tract infections, Pediatric Annals, 28(11), 688-92, 1999
  • A Hoberman, I Fabian, D Kearney (1999) Nurse Practitioner Simulations in Infection Management. University of Pennsylvania School of Nursing, InterMed Press, Darien, CT.
  • M Andrade, A Hoberman, J Glustein, ER Wald, JL Paradise, Acute otitis media in patients with bronchiolitis, Pediatrics, 101, 617-619, 1998
  • Hoberman A, Wald ER, Diagnosis of urinary tract infection in children, American Family Physician, 57, 2337-2340, 1998
  • A Hoberman, JL Paradise (1998) Reply to a Letter to the Editor regarding the Article "Treating Ear Pain in Children with Acute Otitis Media", Archives of Pediatric Adolescent Medicine, 152, 102.
  • Hoberman A, Wald ER, Urinary tract infections in young febrile children, Pediatric Infectious Disease Journal, 16(1), 11-7, 1997 Abstract
  • Hoberman A, Paradise JL, Reynolds EA, Urkin J, Efficacy of Auralgan for treating ear pain in children with acute otitis media, Archives of Pediatrics and Adolescent Medicine, 151(7), 675-8, 1997 Abstract
  • A Hoberman, E Wald, UTI in young children: New light on old questions, Contemporary Pediatrics, 14, 140-156, 1997
  • Hoberman A, Paradise JL, Burch DJ, Valinski WA, Hedrick JA, Aronovitz GH, Drehobl MA, Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children, Pediatric Infectious Disease Journal, 16, 463-470, 1997
  • Hoberman A, Paradise JL, Wald ER, Tympanocentesis technique revisited, Pediatric Infectious Disease Journal, 16(Suppl), S25-6, 1997
  • Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M, Is urine culture necessary to rule out urinary tract infection in young febrile children, Pediatric Infectious Disease Journal, 15, 304-9, 1996
  • Hoberman A, Paradise JL, Block S, Burch DJ, Jacobs MR, Balanescu MI, Efficacy of amoxicillin/clavulanate for acute otitis media: relation to Streptococcus pneumoniae susceptibility, Pediatric Infectious Disease Journal, 15(10), 955-62, 1996
  • Reynolds E, Hoberman A, Diagnosis and management of pyelonephritis in infants, American Journal of Maternal Child Nursing, 20(2), 78-84, 1995 Abstract
  • A Hoberman, ER Wald (1995) Reply to a Letter to the Editor regarding the Article "Pyuria and Bacteriuria in Catheterized Urine Specimens Obtained from Young Children with Fever", Journal of Pediatrics, 126, 158-159.
  • A Hoberman, HP Chao, DM Keller, R Hickey, H Davis, D Ellis (1995) Prevalence of Urinary Tract Infection in Febrile Infants, Year Book of Pediatrics, Stockman, JA III, Editor (Mosby-Year Book Inc., St. Louis, MO), 310.
  • K Patel, M Charron, A Hoberman, ML Brown, KD Rogers (1995) Intra- and Inter-Observer Variability in Interpretation of DMSA Scans Using a Set of Standardized Criteria, Year Book of Diagnostic Radiology, Fedlerle MP, Editor (Mosby-Year Book Inc., St. Louis, MO), 551-554.
  • A Hoberman, ER Wald, EA Reynolds, L Penchansky, M Charron (1995) Pyuria and Bacteriuria in Catheterized Urine Specimens Obtained from Young Children with Fever, Year Book of Emergency Medicine (Mosby-Year Book Inc., St. Louis, MO), 213-214.
  • A Hoberman, ER Wald, EA Reynolds, L Penchansky, M Charron (1995) Pyuria and Bacteriuria in Catheterized Urine Specimens Obtained from Young Children with Fever, Year Book of Family Practice, Berg AO, Editor (Mosby-Year Book Inc., St. Louis, MO), 324-325.
  • A Hoberman, ER Wald, EA Reynolds, L Penchansky, M Charron (1995) Pyuria and Bacteriuria in Catheterized Urine Specimens Obtained from Young Children with Fever, Year Book of Urology, Dekernion JB, Howards SS, Editors (Mosby-Year Book Inc., St. Louis, MO), 301-302.
  • Aspin M, Hoberman A, Aronoff S, McCarty J, McLinn SE, Aronoff S, Lang DJ, Arrieta A, A safety and efficacy comparative study of Clarithromycin and Augmentin suspensions in the treatment of children with acute otitis media, Journal of Pediatrics, 125, 136-141, 1994
  • Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M, Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever, Journal of Pediatrics, 124(4), 513-9, 1994
  • A Hoberman, ER Wald (1994) Reply to a Letter to the Editor Regarding the Article "An Enhanced Urinalysis as a Screening Test for Urinary Tract Infection", Pediatrics, 93, 153-154
  • Hoberman A, Wald ER, Recurrent Acute Otitis Media, Consultant, 55, 121-5, 1993
  • Hoberman A, Paradise JL, Kaleida PH, Ceftriaxone for otitis media, Pediatrics, 92(3), 507, 1993
  • Hoberman A, Chao HP, Keller DM, Hickey R, Davis HW, Ellis D, Prevalence of urinary tract infection in febrile infants, Journal of Pediatrics, 123, 17-23, 1993
  • Hoberman A, Wald ER, Penchansky L,Reynolds EA,Young S, An enhanced urinalysis as a screening test for urinary tract infection, Pediatrics, 91, 1196-9, 1993
  • Patel K, Charron M, Hoberman A, Brown ML, Rogers KD, Intra- and interobserver variability in interpretation of DMSA scans using a set of standardized criteria, Pediatric Radiology, 23(7), 506-9, 1993

Profile Details

Last Updated: 11/13/2006

COS Expertise ID #406151
Reference this profile directly: http://myprofile.cos.com/AHOBERMAN